Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

10
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
10
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

12
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.0K
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

13
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Continued Nintedanib Treatment in Children and Adolescents With Fibrosing ILDs: Data From InPedILD-ON.

Pediatric pulmonology·2026
Same author

Sputum lautropia is decreased in rheumatoid arthritis-associated pulmonary fibrosis.

Arthritis research & therapy·2026
Same author

Development and validation of a rabbit model of <i>Pseudomonas aeruginosa</i> hyperdynamic septic shock for preclinical drug development.

Antimicrobial agents and chemotherapy·2026
Same author

Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statement.

The Lancet. Respiratory medicine·2026
Same author

Idiopathic pulmonary fibrosis risk loci in East Asian populations mirror those of European populations.

American journal of respiratory and critical care medicine·2026
Same author

Quantitative CT Fibrosis ≥10% Identifies High Mortality Risk in RA-ILD Independent of HRCT Pattern.

American journal of respiratory and critical care medicine·2026

相关实验视频

Updated: Jul 23, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.0K

与肌肉炎相关的间歇性肺病.

Trang T T Vu1, Kevin K Brown2, Joshua J Solomon2

  • 1Internal Medicine Department, Hanoi Medical University - Respiratory Center, Bach Mai hospital, Ha Noi, Vietnam.

Current opinion in pulmonary medicine
|July 12, 2023
PubMed
概括

在异形性炎症性肌肉病 (IIM) 中的间歇性肺病 (ILD) 根据自身抗体配置不同. 抗合成酶综合征和抗MDA5抗体是影响ILD特征和治疗策略的关键亚型.

科学领域:

  • 类风湿病学 类风湿病学
  • 肺部病理学 肺部病理学
  • 免疫学 免疫学 免疫学

背景情况:

  • 间歇性肺病 (ILD) 是异常性炎症性肌肉病 (IIM) 的常见并发症,在各大洲的患病率不同.
  • 自体抗体配置文件,包括肌肉炎特异性和肌肉炎相关 (MSA和MAA) 抗体,对于预测IIM临床表型和疾病进展至关重要.

研究的目的:

  • 本综述侧重于IIM内的ILD亚型的特征和管理,特别是与抗合成酶综合征相关的ILD和抗MDA5抗体阳性ILD.
  • 突出IIM中这些流行ILD亚型的临床相关性和独特特征.

主要方法:

  • 审查当前关于异形性炎症性肌肉病和相关间歇性肺部疾病的文献.
  • 分析自身抗体 (MSA和MAA) 概况及其与临床表型和ILD进展的相关性.
  • 对与抗合成酶综合征相关的ILD和抗MDA5阳性ILD的治疗策略的检查.

主要成果:

  • 在IIM中,ILD的流行率在亚洲 (50%) 比北美 (23%) 和欧洲 (26%) 高.
  • 与抗合成酶综合征相关的ILD呈现,进展和预后因特定的抗ARS抗体 (例如,抗PL-7/抗PL-12与抗Jo-1) 而有所不同.
  • 在亚洲人群中,抗MDA5抗体的患病率更高. 抗MDA5阳性ILD经常是快速进展的 (RP-ILD),而抗合成酶综合征可以呈现为慢性惰的ILD.

更多相关视频

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

593
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

491

相关实验视频

Last Updated: Jul 23, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.0K
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

593
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

491

结论:

  • 自体抗体概况显著影响IIM中ILD的临床过程和严重程度.
  • 抗合成酶综合征和抗MDA5阳性ILD代表着不同的临床重要亚型,需要量身定制的管理.
  • 这些ILD亚型的治疗通常涉及皮质类固醇和其他免疫抑制剂的组合.